These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36263437)

  • 1. Comparative and evolutionary analysis of
    Lv S; Jiang Y; Li Y; Huang R; Peng L; Ma Z; Lu N; Lin X; Yan J
    Front Genet; 2022; 13():796291. PubMed ID: 36263437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ripks and Neuroinflammation.
    Xu Y; Lin F; Liao G; Sun J; Chen W; Zhang L
    Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38349514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.
    Lusthaus M; Mazkereth N; Donin N; Fishelson Z
    Front Immunol; 2018; 9():306. PubMed ID: 29527209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of the RIP kinase family members in the skin.
    Urwyler-Rösselet C; Tanghe G; Devos M; Hulpiau P; Saeys Y; Declercq W
    Cell Mol Life Sci; 2023 Sep; 80(10):285. PubMed ID: 37688617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.
    Saleh D; Degterev A
    Curr Top Microbiol Immunol; 2017; 403():37-75. PubMed ID: 26385769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial Roles of the RIP Homotypic Interaction Motifs of RIPK3 in RIPK1-Dependent Cell Death and Lymphoproliferative Disease.
    Zhang H; Wu X; Li X; Li M; Li F; Wang L; Zhang X; Zhang Y; Luo Y; Wang H; Jiang Y; Zhang H
    Cell Rep; 2020 May; 31(7):107650. PubMed ID: 32433959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis.
    Orozco S; Yatim N; Werner MR; Tran H; Gunja SY; Tait SW; Albert ML; Green DR; Oberst A
    Cell Death Differ; 2014 Oct; 21(10):1511-21. PubMed ID: 24902904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide.
    Saleh D; Najjar M; Zelic M; Shah S; Nogusa S; Polykratis A; Paczosa MK; Gough PJ; Bertin J; Whalen M; Fitzgerald KA; Slavov N; Pasparakis M; Balachandran S; Kelliher M; Mecsas J; Degterev A
    J Immunol; 2017 Jun; 198(11):4435-4447. PubMed ID: 28461567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis.
    Someda M; Kuroki S; Miyachi H; Tachibana M; Yonehara S
    Cell Death Differ; 2020 May; 27(5):1539-1553. PubMed ID: 31659279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIP kinases as modulators of inflammation and immunity.
    He S; Wang X
    Nat Immunol; 2018 Sep; 19(9):912-922. PubMed ID: 30131615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
    Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
    Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK protein kinase family: Atypical lives of typical kinases.
    Cuny GD; Degterev A
    Semin Cell Dev Biol; 2021 Jan; 109():96-105. PubMed ID: 32732131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma levels of RIPK1, RIPK3, and MLKL in patients with coronary atherosclerotic heart disease and its clinical predictive value.
    Xiao Z; Zhang Y; Kuang Y; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1096-1103. PubMed ID: 33051424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK3 interactions with MLKL and CaMKII mediate oligodendrocytes death in the developing brain.
    Qu Y; Tang J; Wang H; Li S; Zhao F; Zhang L; Richard Lu Q; Mu D
    Cell Death Dis; 2017 Feb; 8(2):e2629. PubMed ID: 28230861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
    Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
    Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanisms of RIPK1 in cell death and inflammation.
    Liu Z; Chan FK
    Semin Cell Dev Biol; 2021 Jan; 109():70-75. PubMed ID: 32616439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.
    Dillon CP; Weinlich R; Rodriguez DA; Cripps JG; Quarato G; Gurung P; Verbist KC; Brewer TL; Llambi F; Gong YN; Janke LJ; Kelliher MA; Kanneganti TD; Green DR
    Cell; 2014 May; 157(5):1189-202. PubMed ID: 24813850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.